Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Adaptive Designs in Clinical Trials

24th March to 25th March 2014, London, United Kingdom



Due to major changes that have been applied to clinical trials over recent years by both biotech and pharmaceutical companies, the importance of adaptive designs to clinical trials has become more apparent to the industry. The time and cost reductions in the early phase of clinical trials enables less recruitment of patients and improves the general accuracy in clinics. Successful implementation of adaptive designs into a trial however requires unmatched coordination between clinicians, trial managers, statisticians and those involved in the regulation process.

Hear through case studies how all sizes of pharmaceutical companies have successfully implemented trials incorporating adaptive designs. This conference is the only in Europe that focuses on adaptive designs specifically, providing delegates with updates on recent developments in enrichment design, dose response modelling, computer simulation, internal and external regulatory expectations and new data on evaluating adaptive dose ranging studies.

Adaptive Designs in Clinical Trials 2014 aims to show you how you can quickly and accurately implement an adaptive design clinical trial for your drug development - from initial processes in managing trials to choosing the right time to implement change.


Benefits of Attending


Featured Speakers


Who Should Attend